IQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
Follow IQV
IQVIA Holdings Inc. (IQV) Revenue
IQVIA Holdings Inc.'s revenue for fiscal 2025 was $16.3B, up 5.87% from $15.4B in fiscal 2024. Over the twelve months to 30 June 2026 it was $17.0B. Over the past ten years it has ranged from $5.7B (fiscal 2015) to $16.3B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 10 consecutive fiscal years. IQVIA Holdings Inc. ranks 3rd of 50 Diagnostics & Research companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $16.3B | 5.87% |
| FY2024 | $15.4B | 2.81% |
| FY2023 | $15.0B | 3.98% |
| FY2022 | $14.4B | 3.86% |
| FY2021 | $13.9B | 22.14% |
| FY2020 | $11.4B | 2.44% |
| FY2019 | $11.1B | 6.49% |
| FY2018 | $10.4B | 7.32% |
| FY2017 | $9.7B | 42.36% |
| FY2016 | $6.8B | 18.79% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $4.4B | 5.23% |
| Mar 2026 | $4.2B | (4.88%) |
| Dec 2025 | $4.4B | 6.44% |
| Sep 2025 | $4.1B | 2.07% |
| 42 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| IQV IQVIA Holdings Inc. | $17.0B |
| LH Labcorp Holdings Inc. compare | $14.3B |
| DGX Quest Diagnostics Incorporated compare | $11.6B |
| A Agilent Technologies, Inc. compare | $7.4B |
| WAT Waters Corporation compare | $4.6B |
| IDXX IDEXX Laboratories, Inc. compare | $4.6B |
| ILMN Illumina, Inc. compare | $4.5B |
| MTD Mettler-Toledo International, Inc. compare | $4.1B |
| NTRA Natera, Inc. compare | $2.7B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on IQV
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement